​

Tectonic Therapeutic (TECX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

TECX Stock Forecast

Tectonic Therapeutic (TECX) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $78.00, with a high of $81.00 and a low of $75.00. This represents a 121.15% increase from the last price of $35.27.

TECX Stock Rating

Tectonic Therapeutic stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 1 Strong Buy (20.00%), 4 Buy (80.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 4 1 Strong Sell Sell Hold Buy Strong Buy

TECX Price Target Upside V Benchmarks

TypeNameUpside
StockTectonic Therapeutic121.15%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-23
Avg Price Target-$78.00$72.00
Last Closing Price$35.27$35.27$35.27
Upside/Downside-121.15%104.14%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2619---10
Jun, 2619---10
May, 2627---9
Apr, 2626---8
Mar, 2626---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 26, 2026Martin AusterRaymond James$81.00$29.12178.16%129.66%
Apr 13, 2026Stifel Nicolaus$75.00$29.96150.33%112.65%
Jan 08, 2026Danielle BrillTruist Financial$60.00$21.05185.04%70.12%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 26, 2026Raymond JamesOutperformStrong Buyupgrade
Sep 03, 2025OppenheimerOutperforminitialise
Nov 19, 2024Raymond JamesOutperforminitialise
Sep 20, 2024Cowen & Co.BuyBuyhold
Sep 20, 2024Piper SandlerOverweightOverweighthold
Aug 22, 2024Wells FargoOverweightinitialise
Jun 26, 2024Piper SandlerOverweightinitialise
Jun 24, 2024Cowen & Co.Buyinitialise

Financial Forecast

EPS Forecast

$-15 $-11 $-7 $-3 $1 $5 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-11.59$-3.93$-4.05---
Avg Forecast$1.50$-8.02$-5.04$-4.96$-6.73$-8.07
High Forecast$1.50$-4.11$-4.35$-4.96$-6.73$-8.07
Low Forecast$1.50$-12.08$-5.58$-4.96$-6.73$-8.07
Surprise %-872.67%-51.00%-19.64%---

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast------
High Forecast------
Low Forecast------
Surprise %------

Net Income Forecast

$-75M $-58M $-41M $-24M $-7M $10M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-42.82M$-57.98M$-74.15M---
Avg Forecast$5.57M$-29.79M$-18.70M$-18.42M$-24.98M$-29.97M
High Forecast$5.57M$-15.27M$-16.17M$-18.42M$-24.98M$-29.97M
Low Forecast$5.57M$-44.88M$-20.72M$-18.42M$-24.98M$-29.97M
Surprise %-868.68%94.66%296.53%---

TECX Forecast FAQ

Is Tectonic Therapeutic stock a buy?

Tectonic Therapeutic stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Tectonic Therapeutic is a favorable investment for most analysts.

What is Tectonic Therapeutic's price target?

Tectonic Therapeutic's price target, set by 5 Wall Street analysts, averages $78 over the next 12 months. The price target range spans from $75 at the low end to $81 at the high end, suggesting a potential 121.15% change from the previous closing price of $35.27.

How does Tectonic Therapeutic stock forecast compare to its benchmarks?

Tectonic Therapeutic's stock forecast shows a 121.15% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Tectonic Therapeutic over the past three months?

  • July 2026: 10.00% Strong Buy, 90.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 10.00% Strong Buy, 90.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 22.22% Strong Buy, 77.78% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Tectonic Therapeutic’s EPS forecast?

Tectonic Therapeutic's average annual EPS forecast for its fiscal year ending in December 2026 is $-4.96, marking a 22.47% increase from the reported $-4.05 in 2025. Estimates for the following years are $-6.73 in 2027, and $-8.07 in 2028.

What is Tectonic Therapeutic’s revenue forecast?

Tectonic Therapeutic's average annual revenue forecast for its fiscal year ending in December 2026 is $0, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $0, and $0 for 2028.

What is Tectonic Therapeutic’s net income forecast?

Tectonic Therapeutic's net income forecast for the fiscal year ending in December 2026 stands at $-18.418M, representing a -75.16% decrease from the reported $-74.151M in 2025. Projections indicate $-24.983M in 2027, and $-29.972M in 2028.